Fovea Pharmaceuticals

Company profile

Fovea Pharmaceuticals was set up in 2005 to research and develop drugs for treating ophthalmologic disorders, such as age-related macular degeneration, retinitis pigmentosa and diabetic retinopathy. Fovea has developed a range of products in different stages of testing, from pre-clinical products to products about to undergo clinical testing. Over recent years Fovea has signed exclusive cooperation agreements with CombinatorRx Inc. and Novartis.

Press releases

Fovea Pharmaceuticals
  • Activity: Ophthalmologic disorder drugs
  • Website:
  • Location: France
  • Entry: 2005
  • Platform: Health & Care